- Home
- PFBC vs CERT Comparison
PFBC vs CERT Comparison
Compare PFBC & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFBC | CERT |
|---|---|---|
| Founded | 1991 | 2008 |
| Country | United States | United States |
| Employees | 324 | N/A |
| Industry | Major Banks | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | PFBC | CERT |
|---|---|---|
| Price | $87.74 | $6.55 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $102.67 | $12.22 |
| AVG Volume (30 Days) | 80.1K | ★ 3.3M |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | ★ 3.58% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | $2.94 | $5.05 |
| Revenue Next Year | $8.31 | $5.73 |
| P/E Ratio | $8.85 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $73.08 | $6.04 |
| 52 Week High | $103.05 | $15.38 |
Technical Indicators
Market Signals| Indicator | PFBC | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 42.29 | 36.58 |
| Support Level | $84.63 | $6.04 |
| Resistance Level | $94.25 | $7.52 |
| Average True Range (ATR) | 2.34 | 0.36 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 43.76 | 21.49 |
Price Performance
Historical ComparisonAbout PFBC Preferred Bank
Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking, which include Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.